NURIX THERAPEUTICS INC COM is a security (CUSIP 67080M103) tracked across SEC portfolio filings. 202 institutional managers reported $1.8B on Form 13F as of 2026-06-30; 19 registered fund positions totaling $87.4M via N-PORT as of 2026-05-31.
Showing 15 of 202 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| BlackRock, Inc. | New York, NY | $138.3M | 8,925,642 |
| Redmile Group, LLC | San Francisco, CA | $119.9M | 7,732,808 |
| VANGUARD GROUP INC | Valley Forge, PA | $112.9M | 5,949,512 |
| Vestal Point Capital, LP | NEW YORK, NY | $100.8M | 6,500,000 |
| Deep Track Capital, LP | GREENWICH, CT | $98.4M | 6,345,244 |
| FMR LLC | BOSTON, MA | $85.9M | 5,541,271 |
| STATE STREET CORP | BOSTON, MA | $79.7M | 5,141,195 |
| MORGAN STANLEY | NEW YORK, NY | $76.4M | 4,931,999 |
| BAKER BROS. ADVISORS LP | NEW YORK, NY | $72.2M | 4,658,556 |
| GENERAL ATLANTIC, L.P. | New York, NY | $63.6M | 4,101,865 |
| PERCEPTIVE ADVISORS LLC | NEW YORK, NY | $57.5M | 3,710,877 |
| Pictet Asset Management Holding SA | CAROUGE, V8 | $57.0M | 2,351,232 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $39.1M | 2,520,229 |
| Rubric Capital Management LP | New York, NY | $38.3M | 2,473,885 |
| DEUTSCHE BANK AG\ | Frankfurt Am Main, 2M | $35.6M | 2,295,024 |
Showing 15 of 19 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $18.8M | 17.29% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $16.7M | 2.05% |
| SMALLCAP World Fund Inc | SMALLCAP World Fund Inc | $13.8M | 1.71% |
| Fidelity Growth Company Fund | Fidelity Mt. Vernon Street Trust | $11.5M | 1.16% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $9.3M | 5.29% |
| T. Rowe Price New Horizons Fund, Inc. | T. ROWE PRICE NEW HORIZONS FUND, INC. | $5.5M | 4.32% |
| U.S. MICRO CAP PORTFOLIO | DFA INVESTMENT DIMENSIONS GROUP INC | $3.9M | 5.15% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $2.6M | 5.29% |
| VANGUARD MARKET NEUTRAL FUND | VANGUARD MONTGOMERY FUNDS | $1.4M | 32.31% |
| T. Rowe Price Health Sciences Portfolio | T. ROWE PRICE EQUITY SERIES, INC. | $1.1M | 17.24% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $904K | 0.15% |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | VANGUARD INSTITUTIONAL INDEX FUNDS | $787K | 0.26% |
| Fidelity Nasdaq Composite Index ETF | Fidelity Commonwealth Trust | $684K | 0.63% |
| DWS Small Cap Index VIP | DEUTSCHE DWS INVESTMENTS VIT FUNDS | $220K | 5.25% |
| Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF | Goldman Sachs ETF Trust | $198K | 2.01% |